Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) CFO Sells $575,150.00 in Stock
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Get Free Report) CFO Octavio Espinoza sold 5,000 shares of Ligand Pharmaceuticals stock in a transaction that occurred on Tuesday, March 4th. The shares were sold at an average price of $115.03, for a total value of $575,150.00. Following the sale, the chief financial officer now directly owns 18,879 shares […]
